Symptomatic hypocalcaemia after treatment with zoledronic acid in a patient with multiple myeloma

被引：10

作者：

Singh, D ^{[1
]}

Khaira, NS ^{[1
]}

Sekhon, JS ^{[1
]}

机构：

[1] Dayanand Med Coll & Hosp, Ludhiana 141001, Punjab, India

来源：

ANNALS OF ONCOLOGY | 2004年 / 15卷 / 12期

关键词：

D O I：

10.1093/annonc/mdh479

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

收藏

页码：1848 / 1848

页数：1

相关论文

共 4 条

[1] A dose-finding study of zoledronate in hypercalcemic cancer patients [J].

Body, JJ ;

Lortholary, A ;

Romieu, G ;

Vigneron, AM ;

Ford, J .

JOURNAL OF BONE AND MINERAL RESEARCH, 1999, 14 (09) :1557-1561

[2] Prolonged hypocalcemia after treatment with zoledronic acid in a patient with prostate cancer and vitamin D deficiency [J].

Breen, TL ;

Shane, E .

JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (08) :1531-1532

[3] Zoledronic acid in the treatment of hypercalcemia of malignancy: Results of the international clinical development program [J].

Major, PP ;

Coleman, RE .

SEMINARS IN ONCOLOGY, 2001, 28 (02) :17-24

[4] Zoledronic acid - A review of its use in the management of bone metastases and hypercalcaemia of malignancy [J].

Wellington, K ;

Goa, KL .

DRUGS, 2003, 63 (04) :417-437